Sometimes, the care you are already receiving does not fully address how you feel. If persistent pain, fatigue, or inflammation remains a concern, LDN treatment in Willoughby, OH may be an option to explore with a qualified provider.
At JLUXE Aesthetics, low-dose naltrexone is approached as part of individualized care. We review your health history, medications, and goals during a consultation to determine whether this treatment may be appropriate for you.
Low-dose naltrexone (LDN) is a lower-dose form of naltrexone, typically prescribed in doses ranging from 0.5 to 4.5 mg. Unlike standard-dose naltrexone, which has FDA-approved uses for alcohol and opioid use disorders, low-dose naltrexone is prescribed off-label. Research into LDN for concerns such as chronic pain and inflammation is ongoing, and evidence varies by condition.
LDN therapy may be considered for people exploring additional support for concerns such as pain, inflammation, or fatigue. Because LDN is not appropriate for everyone, your provider will review your health history, medications, and goals before recommending a dose or treatment plan.
At low doses, naltrexone temporarily blocks opioid receptors. Researchers have proposed that this temporary blockade may affect the body’s natural opioid and endorphin signaling, which plays a role in pain regulation.
LDN may also influence TLR4 signaling in microglia, immune cells in the central nervous system that can contribute to inflammatory signaling when activated. These effects are being studied as possible pathways through which LDN may influence inflammation and immune activity.
LDN’s effects on opioid receptors and inflammatory pathways have led to interest in several areas of supportive care. Here are some of the concerns for which LDN has been studied.
LDN may influence inflammatory signaling by affecting microglial activity and other immune processes. This may help regulate the inflammatory response rather than directly treating an underlying condition. Research continues to examine these potential effects.
By influencing the body’s opioid signaling, LDN may affect how certain types of discomfort are processed. It has been studied particularly for persistent and nerve-related discomfort. This may make it a supportive option alongside other approaches to symptom management.
LDN has also been explored for concerns such as persistent fatigue and changes in overall well-being. Its effects on endorphin signaling and inflammatory pathways may play a role in these areas. However, research varies across different wellness concerns.
When LDN is appropriate for you, there may be practical advantages to incorporating it into your care:
LDN is taken by mouth, so it does not require injections or in-office procedures. A daily medication can also fit more easily into your existing routine.
LDN dosing can be adjusted based on how you respond to treatment. Your provider can make changes as needed rather than relying on a fixed dose for every patient.
LDN can be added to a broader approach to your health when appropriate. It does not have to replace the care or treatments you are already receiving.
Follow-up visits provide an opportunity to review how you are responding and whether your treatment plan needs to change.
There is no single approach that works for every person. LDN may be worth exploring if you want to consider another avenue for your care and see whether it aligns with what you are looking for.
Every LDN plan starts with a detailed look at your health history, current needs, and treatment goals. From there, dosing can be adjusted based on how you respond to treatment.
LDN can raise plenty of questions, especially when you are considering it for an ongoing concern. We can explain how it works, what you can expect, and whether it makes sense for your care.
You are supported throughout the process, from the first consultation to follow-up visits. If questions come up or your response changes, you have a team you can turn to and discuss what comes next.
LDN does not have to replace the care you already receive. When appropriate, it can be considered as part of a broader treatment plan. The table below highlights some general differences in how LDN and standard-dose naltrexone are typically approached.
| LDN Through JLUXE | Traditional Standard-Dose Care | |
|---|---|---|
| Treatment Approach | Low-dose naltrexone used off-label as part of a supportive treatment plan | Standard-dose naltrexone used for its approved indications |
| Dosing | Dose may be adjusted based on how you respond to treatment | Dosing generally follows established guidelines for the approved use |
| Patient Involvement | Regular communication about changes, concerns, and how treatment is going | Involvement varies based on the treatment and provider |
| Follow-Up | Follow-up visits provide an opportunity to review your response and discuss adjustments | Follow-up needs vary depending on the treatment and condition |
| Ongoing Care | Treatment can be reviewed over time based on your response and goals | Ongoing care depends on the medication, condition, and treatment plan |
LDN treatment uses a much lower dose of naltrexone, typically 0.5 to 4.5 mg, and is prescribed off-label as part of a supportive care plan. Standard-dose naltrexone is FDA-approved for treating alcohol use disorder and preventing the effects of opioids.
LDN may be considered as part of supportive care for concerns such as chronic pain, fatigue, and inflammation. Because these uses are off-label and research is still developing, a consultation can help determine whether LDN may be appropriate for your needs.
At low doses, naltrexone temporarily blocks opioid receptors. Researchers have proposed that this temporary blockade may affect the body’s natural opioid and endorphin signaling.
LDN has also been studied for its potential effects on immune activity and inflammatory signaling, although research into these effects is still ongoing.
There is no set timeline. Some people notice gradual changes, while others may not notice a meaningful difference. Your provider will check in with you at follow-up visits to review how you are responding.
Available studies suggest LDN is generally well tolerated, although side effects can occur. Because individual circumstances can affect whether it is suitable, your provider will review your medications and health history before recommending treatment.
LDN should not be taken with opioid-containing medications, making a proper review an important part of starting care.
Candidacy depends on your medical history, current medications, and goals. People who are exploring supportive options for ongoing concerns and are willing to work closely with a provider may be good candidates for a consultation.
The length of treatment varies. Your provider will evaluate your progress at follow-up visits and help you decide whether to continue, adjust, or stop.
Yes. A consultation with a medical history review and provider evaluation is required before starting treatment.
Yes. Your provider sets and adjusts your dose based on your health history, goals, and response to treatment.
If LDN is something you are considering, JLUXE Aesthetics is here to help you get started. Reach out to us today.
Jennifer DeMarco, FNP-C, MSN is a board-certified family nurse practitioner and the owner of JLUXE Aesthetics, where she leads with a blend of clinical expertise, integrative philosophy, and personalized care.
DeMarco earned her Bachelor of Science in Nursing from Ohio University and her Master of Science in Nursing with a specialization in Family Practice from Case Western Reserve University, a nationally recognized institution known for its innovation in medical education.
She began her career in the operating room before transitioning into primary care, where she developed a strong focus on integrative and preventative medicine. Her passion for addressing root causes and treating the whole patient shaped the foundation of JLUXE — a practice centered on helping clients feel their best from the inside out.
As a certified hormone specialist through the BHRT Academy, DeMarco trained under hormone expert Deborah Matthews, gaining advanced expertise in hormone balancing and functional wellness. This allows her to support patients with a deeper, more individualized approach to care.
As the owner of JLUXE Aesthetics, DeMarco is committed to providing results-driven, compassionate treatments that elevate confidence, health, and long-term vitality.
Christina Palmer, RN, BSN is a registered nurse with over eight years of clinical and leadership experience in the medical field. She currently serves as the Clinical Aesthetics Director at JLUXE Aesthetics, where she combines her extensive patient care background with a strong focus on team development, business growth, and aesthetic excellence.
Palmer earned her Bachelor of Science in Nursing and began her career at Cleveland Clinic, one of the nation’s top-ranked hospitals, where she held a leadership role overseeing clinical operations and nursing staff. Her tenure at Cleveland Clinic allowed her to cultivate a deep expertise in patient-centered care, operational strategy, and relationship building within high-performing medical teams.
In recognition of her outstanding leadership and contributions to healthcare, Palmer received the Pinnacle Award, a testament to her commitment to excellence and innovation in clinical practice.
At JLUXE Aesthetics, Palmer is known not only for her professional achievements but also for her approachable, warm demeanor and genuine passion for helping others feel their best. Her ability to lead with empathy while delivering measurable results makes her an integral part of JLUXE’s mission and future.
Donato J. Borrillo is a physician and attorney with extensive experience in medical and legal fields. He has a keen interest in wellness and aesthetic medicine and serves as a Senior Medical Physician for Norwegian Cruise Lines.
Borrillo is a 1994 graduate of Case Western Reserve University School of Law in Cleveland, Ohio, and a 1986 graduate of Canisius College in Buffalo, New York. He is a 1990 graduate of the State University of New York at Buffalo School of Medicine. He interned at Cook County Hospital, Chicago, IL, and completed residency at Wright State University, Dayton, OH.
Borrillo is board certified by the American Board of Preventive Medicine and has a master of science degree in immunology from Roswell Park Cancer Institute, Buffalo, NY, as well as a master of science degree in aerospace medicine, from Wright State University, Dayton, OH.
After his medical residency, he practiced as a flight surgeon with the United States Air Force from 1996 through 2001, and he was assigned to the Special Operations Command in Europe and Africa. Borrillo was honorably discharged as a major after nine years of military service and was a visiting scholar at Cambridge University, England, from 1998 -1999, while serving at Royal Air Force Mildenhall, England.
He serves as assistant general counsel and director of medical legal affairs at the Institute of Law and Justice, Bryan Texas, and is licensed to practice medicine in Ohio and multiple states. Borrillo is actively involved in community service, teaching medical students at the University of Toledo Medical Center and is on staff with the University of Michigan, Sparrow Hospital.
SERVICES: Hydrafacials, ZO Facials, Skin Care Consults & Follow ups, teeth whitening
CERTIFICATIONS:
